BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16651236)

  • 1. The evaluation of blood donor deferral causes.
    Gülen H; Tüzün F; Ayhan Y; Erbay A; Oztürk E; Inan S; Vergin C
    Pediatr Hematol Oncol; 2006 Mar; 23(2):91-4. PubMed ID: 16651236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service.
    Charles KS; Hughes P; Gadd R; Bodkyn CJ; Rodriguez M
    Transfus Med; 2010 Feb; 20(1):11-4. PubMed ID: 19788640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main causes of pre-donation deferral of prospective blood donors in the Singapore Blood Transfusion Service.
    Lim JC; Tien SL; Ong YW
    Ann Acad Med Singap; 1993 May; 22(3):326-31. PubMed ID: 8373113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
    Polizzotto MN; Wood EM; Ingham H; Keller AJ;
    Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stating technical requirements and deferral criteria for whole blood donation].
    Danic B
    Transfus Clin Biol; 2005 Jul; 12(3):287-9. PubMed ID: 15963750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of deferrals for tattooing and piercing.
    Goldman M; Xi G; Yi QL; Fan W; O'Brien SF
    Transfusion; 2009 Apr; 49(4):648-54. PubMed ID: 19171003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pre-donation deferrals--a teaching hospital experience.
    Rabeya Y; Rapiaah M; Rosline H; Ahmed SA; Zaidah WA; Roshan TM
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):571-4. PubMed ID: 18564700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
    de Almeida Neto C; McFarland W; Murphy EL; Chen S; Nogueira FA; Mendrone A; Salles NA; Chamone DA; Sabino EC
    Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and biological qualifications for blood donations].
    Danic B; Piquet Y
    Rev Prat; 2001 Jun; 51(12):1299-305. PubMed ID: 11503502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
    Maresch C; Schluter PJ; Wilson AD; Sleigh A
    Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood donation!].
    Jørgensen VR; Rosted P
    Ugeskr Laeger; 2002 Aug; 164(32):3789-90; author reply 3790. PubMed ID: 12362617
    [No Abstract]   [Full Text] [Related]  

  • 14. Directed blood donation in pediatric general surgery: Is it worth it?
    Wales PW; Lau W; Kim PC
    J Pediatr Surg; 2001 May; 36(5):722-5. PubMed ID: 11329574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferral patterns of voluntary blood donors at the National Blood Transfusion Service, North East Zonal Centre, Maiduguri.
    Kagu MB; Ahmed SG; Bashir MA; Malah MB; Usoro A; Gimba I; Babakura Y; Elisha J
    Afr J Med Med Sci; 2010 Jun; 39(2):119-25. PubMed ID: 21117408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies.
    O'brien SF; Chiavetta JA; Goldman M; Fan W; Nair RC; Sher GD; Vamvakas EC
    Transfusion; 2006 Mar; 46(3):461-8. PubMed ID: 16533291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does blood donor history accurately reflect the use of prescription medications? A comparison of donor history and serum toxicologic analysis.
    Melanson SE; Stowell CP; Flood JG; Lewandrowski EL; Zak RJ; Lewandrowski KB
    Transfusion; 2006 Aug; 46(8):1402-7. PubMed ID: 16934078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparing for inspection: managing regulations and practices surrounding donors with positive infectious disease testing.
    Ferschke J
    J Clin Apher; 2008; 23(6):191-5. PubMed ID: 18973114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donor deferrals for malaria on blood availability in the United States.
    Leiby DA; Nguyen ML; Notari EP
    Transfusion; 2008 Oct; 48(10):2222-8. PubMed ID: 18673351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania: risk to the blood supply.
    Cardo LJ
    Transfusion; 2006 Sep; 46(9):1641-5. PubMed ID: 16965594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.